Accessibility Menu
 
Bluejay Diagnostics logo

Bluejay Diagnostics

(NASDAQ) BJDX

Current Price$1.95
Market Cap$1.90M
Since IPO (2021)-100%
5 YearN/A
1 Year-87%
1 Month+0%

Bluejay Diagnostics Financials at a Glance

Market Cap

$1.90M

Revenue (TTM)

$0.00

Net Income (TTM)

$6.85M

EPS (TTM)

$-25.53

P/E Ratio

-0.08

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.95

Volume

10,004

Open

$1.88

Previous Close

$1.95

Daily Range

$1.81 - $1.95

52-Week Range

$1.65 - $40.80

BJDX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bluejay Diagnostics

Industry

Healthcare Equipment and Supplies

Employees

6

CEO

Indranil Dey, PhD, MBA

Headquarters

Acton, MA 01720, US

BJDX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-117%

Return on Capital

-1%

Return on Assets

-96%

Earnings Yield

-12.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.90M

Shares Outstanding

972.20K

Volume

10.00K

Short Interest

0.00%

Avg. Volume

225.03K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$6.95M

EBITDA

$6.68M

Operating Cash Flow

$6.05M

Capital Expenditure

$173.74K

Free Cash Flow

$6.23M

Cash & ST Invst.

$5.16M

Total Debt

$120.21K

Bluejay Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$48.81K

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.90M

N/A

Market Cap/Employee

$270.83K

N/A

Employees

7

N/A

Net Income

$1.43M

+0.2%

EBITDA

$1.38M

+0.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$5.04M

+23.4%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$24.75K

-77.3%

Short Term Debt

$104.81K

-7.5%

Return on Assets

-96.20%

N/A

Return on Invested Capital

-1.16%

N/A

Free Cash Flow

$1.63M

+6.4%

Operating Cash Flow

$1.45M

+16.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UPCUniverse Pharmaceuticals Inc.
$3.16+15.75%
TIVCTivic Health Systems, Inc.
$1.00-1.01%
VTAKCatheter Precision, Inc.
$0.93-1.06%
MSPRMSP Recovery, Inc.
$0.03+6.53%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
NVDANvidia
$177.39+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%

Questions About BJDX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.